Golden State Equity Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
Golden State Equity Partners's PFE Position: Q2 2026 in Review
Golden State Equity Partners sold out of Pfizer (PFE) in Q2 2026, closing a stake of 69,810 shares — an estimated $1.96M sold.
Golden State Equity Partners first reported a position in PFE in Q4 2020 and held it in 17 quarters. The position peaked at $1.96M in Q1 2026. 1,393 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Golden State Equity Partners reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Golden State Equity Partners sold 69,810 Pfizer shares in Q2 2026, an estimated $1.96M.
- Golden State Equity Partners first reported a position in Pfizer in Q4 2020 and held it in 17 quarters.
- Golden State Equity Partners's Pfizer position peaked at $1.96M in Q1 2026.
- 1,393 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.